Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Follicular Unit Excision (FUE) is a popular, safe hair transplant method that avoids scars and has a quick recovery, but requires precise surgical skill.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Tofacitinib helped a woman regrow hair with no major side effects.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

FUE hair transplant is a promising method with benefits like less scarring, but requires a skilled surgeon and can damage hair follicles.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Compound 6 is a promising candidate for better wound healing.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Phenoxyethanol in hair growth products may be linked to frontal fibrosing alopecia.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

It's important to understand the differences between FMF and PFM in children.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.